Oxycodone - ALZA Corporation
Alternative Names: OROS® oxycodoneLatest Information Update: 08 Jan 2022
At a glance
- Originator ALZA Corporation
- Class Alkaloids; Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 28 Jun 2001 ALZA Corporation has been acquired by Johnson & Johnson
- 07 Jun 2001 Investigation in Pain in USA (PO)